TY - JOUR
KW - Humans
KW - *Hyperuricemia/drug therapy/blood/epidemiology/complications
KW - Male
KW - *Heart Failure/epidemiology/drug therapy/mortality
KW - Female
KW - Aged
KW - United Kingdom/epidemiology
KW - Retrospective Studies
KW - *Uric Acid/blood
KW - *Gout Suppressants/therapeutic use
KW - Risk Factors
KW - Middle Aged
KW - Biomarkers/blood
KW - Treatment Outcome
KW - Gout/drug therapy/blood/complications/epidemiology
KW - Time Factors
KW - Databases, Factual
KW - Follow-Up Studies
KW - gout
KW - heart failure
KW - hyperuricemia
KW - urate‐lowering therapy
KW - analysis and manuscript development.
AU - S. Kiddle
AU - K. Sundell
AU - S. Perl
AU - S. Nolan
AU - M. Bjursell
AD - Data Science & Advanced Analytics, Data Science & Artificial Intelligence, R&D, AstraZeneca, Cambridge, UK.
Cardiovascular, Renal and Metabolic (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
Late-stage Development, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Late-stage Development, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Global Medical Affairs, Clinical, Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
AN - 38873862
BT - Clin Cardiol
C2 - PMC11177015
DO - 10.1002/clc.24297
DP - NLM
ET - 2024/06/14
LA - eng
M1 - 6
N1 - 1932-8737
Kiddle, Steven J
Orcid: 0000-0003-4350-7437
Sundell, Karolina Andersson
Perl, Shira
Nolan, Stephen
Bjursell, Magnus
AstraZeneca/
Journal Article
Multicenter Study
United States
Clin Cardiol. 2024 Jun;47(6):e24297. doi: 10.1002/clc.24297.
PY - 2024
SN - 0160-9289 (Print)
0160-9289
EP - e24297
T2 - Clin Cardiol
TI - Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink
VL - 47
ER -